L Petramala
Overview
Explore the profile of L Petramala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tarallo M, Petramala L, Altieri B
Front Oncol
. 2023 Jul;
13:1220372.
PMID: 37409262
No abstract available.
2.
Concistre A, Petramala L, Pugliano C, Celi M, Vinci F, Assanto E, et al.
Eur Rev Med Pharmacol Sci
. 2023 Feb;
27(3):1207-1221.
PMID: 36808370
Objective: COVID-19 clinical presentation ranges from asymptomatic infection to an inflammatory cytokine storm with multi-organ failure and fatal outcomes. The identification of high-risk patients for severe disease is crucial to...
3.
Petramala L, Concistre A, Mezzadri M, Sarlo F, Circosta F, Schina M, et al.
Int J Cardiol Cardiovasc Risk Prev
. 2022 Sep;
14:200138.
PMID: 36060288
Purpose: Aldosterone plays important role in cardiovascular damage. Aim was to evaluate arterial subclinical damage through arterial stiffness parameters in patients with Essential Hypertension (EH) and Primary Aldosteronism (PA). Methods:...
4.
De Sio S, Letizia C, Petramala L, Saracino V, Cedrone F, Sanguigni P, et al.
Eur Rev Med Pharmacol Sci
. 2018 Dec;
22(24):9012-9017.
PMID: 30575947
Objective: Chronic exposure to work-related stress (WRS) stimulates the hypothalamic-pituitary-adrenal (HPA) axis to increase glucocorticoid secretion, including cortisol, and these hormones can be measured both in serum and urine. The...
5.
Papi P, Letizia C, Pilloni A, Petramala L, Saracino V, Rosella D, et al.
Eur Rev Med Pharmacol Sci
. 2018 Mar;
22(4):866-875.
PMID: 29509232
Objective: Metabolic syndrome (MetS) is defined as a spectrum of conditions associated with an increased risk of developing CVD and type 2 diabetes. MetS include: hyperglycemia, hypertension, visceral obesity, dyslipidemia...
6.
Concistre A, Grillo A, La Torre G, Carretta R, Fabris B, Petramala L, et al.
Endocrine
. 2017 Jul;
60(1):129-137.
PMID: 28702887
Introduction: Primary hyperparathyroidism is associated with a cluster of cardiovascular manifestations, including hypertension, leading to increased cardiovascular risk. Purpose: The aim of our study was to investigate the ambulatory blood...
7.
Vingolo E, Fragiotta S, Mafrici M, Cutini A, Marinelli C, Concistre A, et al.
Eur Rev Med Pharmacol Sci
. 2017 Mar;
21(4):662-668.
PMID: 28272719
Objective: To assess vitreous and plasma changes of vascular endothelial growth factor A (VEGF-A), adrenomedullin (ADM) and endothelin-1 (ET-1) in proliferative diabetic retinopathy (PDR). Patients And Methods: 9 patients with...
8.
Petramala L, Iacobellis G, Carnevale R, Marinelli C, Zinnamosca L, Concistre A, et al.
Horm Metab Res
. 2016 Apr;
48(7):440-5.
PMID: 27101095
Primary aldosteronism (PA) is one of the most frequent forms of secondary hypertension, associated with atherosclerosis and higher risk of cardiovascular events. Platelets play a key role in the atherosclerotic...
9.
Iacobellis G, Petramala L, Marinelli C, Calvieri C, Zinnamosca L, Concistre A, et al.
Horm Metab Res
. 2016 Mar;
48(4):238-41.
PMID: 26983926
Primary aldosteronism (PA) is associated with increased cardiovascular risk and left ventricle (LV) changes. Given its peculiar biomolecular and anatomic properties, excessive epicardial fat, the heart-specific visceral fat depot, can...
10.
Zavatto A, Concistre A, Marinelli C, Zingaretti V, Umbro I, Fiacco F, et al.
Eur Rev Med Pharmacol Sci
. 2015 Nov;
19(20):3910-6.
PMID: 26531278
Rhabdomyolysis is a rare presentation of hypokalemia, although muscle weakness is a well-known manifestation of hypokalemia. Primary aldosteronism is characterized by hypertension, suppressed plasma renin activity, increased aldosterone excretion and...